Laurie Toich, Assistant Editor

Top news of the day from across the health care landscape.

Tramadol extended-release could address the growing problem of opioid misuse disorder.

Large group employers report significant cost challenges associated with specialty drugs.

Integrating medical and pharmacy benefits may better inform employer management of specialty drugs.

Novel drug may increase immune system attack against cancer cells in patients with myelodysplastic syndrome.

One-third of patients with myelodysplastic syndrome progress to acute myeloid leukemia.

Outreach efforts seek to address rates of undiagnosed hepatitis C virus among homeless veterans.

Copper-embedded plastic may reduce bioburden from infectious bacteria in hospitals.

While overall hospitalizations for heart failure decreased, problems persist among minority populations.

The Alexa Diabetes Challenge harnesses voice-activated technology to improve diabetes outcomes.

Top news of the day from across the healthcare landscape.

Patients with depression who present low back pain likely to receive double the dose of opioids.

Nonsteroidal anti-inflammatory drugs may reduce disease-related death among colorectal cancer survivors.

The ClearLLAb Reagents test can detect cancer cells in the blood.

Parkinson’s disease risk observed to be heightened within 2.5 years of taking statins in at-risk patients.

Neratinib (Nerlynx) indicated to prevent breast cancer recurrence.

Neratinib, a kinase inhibitor, is indicated to follow therapy with trastuzumab to prevent breast cancer recurrence.

A panel of experts found encouraging data for cognitive training, hypertension management, and exercise.

Top news of the day from across the healthcare landscape.

Biosimilar to trastuzumab (Herceptin) observed to have no clinically significant differences than the reference product.

Trastuzumab is indicated as an adjuvant therapy for HER2-positive breast cancer, along with metastatic breast and gastric cancers.

Acupuncture therapy may help lessen the need for opioid pain medication.

SmartMat offers early protection against nontraumatic plantar foot ulcers foot ulcers before presentation.

New cases of hepatitis C virus increased among young men by 55% in 2015.

Biomarker status could indicate palbociclib resistance in patients with estrogen receptor-positive breast cancer.

Certain biomarkers influence outcomes in breast cancer patients treated with palbociclib.

Top news of the day from across the healthcare landscape.

Biosimilars have the potential to achieve billions in savings, but significant challenges remain.

Express Scripts reports that the emergence of 11 biosimilars could result in $250 billion in savings over the next decade.

Amlexanox may alter genes that improve blood glucose control in patients with type 2 diabetes.